s6y

3 Sucampo Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0000950103-12-003138

Documents

  1. PRIMARY DOCUMENT 3
  2. PRIMARY DOCUMENT 3

On sec.gov